Page 4 - விட்ஸ் தடுப்பு மருந்துகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from விட்ஸ் தடுப்பு மருந்துகள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In விட்ஸ் தடுப்பு மருந்துகள் Today - Breaking & Trending Today

Easter 'super spreader' events could trigger third Covid-19 wave in SA

Easter super spreader events could trigger third Covid-19 wave in SA
By Shaun Smillie, Norman Cloete
Mar 13, 2021
The Covid-19 third wave is coming.
The concern is that super spreader events allowed over Easter may trigger a tide of new infections.
In a couple of weeks or months, a third Covid-19 wave is set to hit South Africa. But as yet, academics don’t know how deadly or wide spread it will be.
Currently the number of Covid-19 infections is falling, and South Africans are enjoying the last days of summer after lockdown restrictions were eased. But, in a couple of weeks or months, stricter lockdown restrictions are likely to return as the country experiences a new surge of Covid-19 infections. ....

South Africa , United Kingdom , Western Cape , South African , South Africans , Shabir Madhi , Novavax Covid , Nandi Siegfried , Alex Welte , Infectious Diseases Analytics Research Unit , Wits University , College Of Public Health Medicine , Covid Task Team , Security Systems Administration , Department Of Epidemiology At Stellenbosch University , Wits School Of Governance , Professor Alex , Social Security Systems Administration , Management Studies , Wits School , Executive Director , Wits Vaccines , South Eastern , Saturday Star , Public Health Medicine , Stellenbosch University ,

Latest - Novavax Covid-19 vaccine trial results in SA and UK confirm high levels of efficacy

Latest - Novavax Covid-19 vaccine trial results in SA and UK confirm high levels of efficacy
wits.ac.za - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wits.ac.za Daily Mail and Mail on Sunday newspapers.

South Africa , United Kingdom , South African , Shabir Madhi , Novavax Covid , Stanleyc Erck , Research Unit , Executive Director , Wits Vaccines , Infectious Diseases Analytics , Chief Executive Officer , South African Novavax , ஒன்றுபட்டது கிஂக்டம் , ஷபீர் மதி , ஆராய்ச்சி அலகு , நிர்வாகி இயக்குனர் , விட்ஸ் தடுப்பு மருந்துகள் , தொற்று நோய்கள் பகுப்பாய்வு , தலைமை நிர்வாகி அதிகாரி ,

2021-03 - Novavax Covid-19 vaccine trial results in SA and UK confirm high levels of efficacy

2021-03 - Novavax Covid-19 vaccine trial results in SA and UK confirm high levels of efficacy
wits.ac.za - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wits.ac.za Daily Mail and Mail on Sunday newspapers.

South Africa , United Kingdom , South African , Shabir Madhi , Novavax Covid , Stanleyc Erck , Research Unit , Executive Director , Wits Vaccines , Infectious Diseases Analytics , Chief Executive Officer , South African Novavax , ஒன்றுபட்டது கிஂக்டம் , ஷபீர் மதி , ஆராய்ச்சி அலகு , நிர்வாகி இயக்குனர் , விட்ஸ் தடுப்பு மருந்துகள் , தொற்று நோய்கள் பகுப்பாய்வு , தலைமை நிர்வாகி அதிகாரி ,

Novavax vaccine offers protection against COVID-19 variants found in SA, UK

The executive director of the Wits Vaccines and Infectious Diseases Analytics Research Unit, Professor Shabir Madhi, said that an updated analysis of the Novavax vaccine trial in South Africa showed vaccine efficacy of 55.4% against mainly mild COVID-19 among HIV-negative trial participants. ....

South Africa , United Kingdom , South African , Shabir Madhi , Graig Lee Smith , Infectious Diseases Analytics Research Unit , Wits Vaccines , Professor Shabir Madhi , Lee Smith , Corona Virus , Coronavirus Vaccine , Covid 19 , Covid 19 Vaccine , Novavax Vaccine , ஒன்றுபட்டது கிஂக்டம் , ஷபீர் மதி , கிரைக் லீ ஸ்மித் , தொற்று நோய்கள் பகுப்பாய்வு ஆராய்ச்சி அலகு , விட்ஸ் தடுப்பு மருந்துகள் , ப்ரொஃபெஸர் ஷபீர் மதி , லீ ஸ்மித் , கொரோனா வைரஸ் ,

Pfizer COVID-19 Vaccine Proven 'Less Effective' Against South African Virus - IT News Africa - Up to date technology news, IT news, Digital news, Telecom news, Mobile news, Gadgets news, Analysis and Reports

A lab study by Pfizer and BioNTech has shown that its COVID-19 vaccine has proven ‘less effective’ against the South African variant by producing “lower levels of neutralizing antibodies”. According to Bloomberg, the results are “part of tests of its vaccine against a lab-created virus that had all the mutations found in the South African […] ....

South Africa , United Kingdom , South African , Sarah Gilbert , University Of Oxford , Astrazeneca Plc , Wits Vaccines , Infectious Diseases Analytics , ஒன்றுபட்டது கிஂக்டம் , சாரா கில்பர்ட் , பல்கலைக்கழகம் ஆஃப் ஆக்ஸ்ஃபர்ட் , விட்ஸ் தடுப்பு மருந்துகள் , தொற்று நோய்கள் பகுப்பாய்வு ,